Duragesic

Duragesic® (Fentanyl Transdermal System “pain patch”), manufactured by the Johnson & Johnson subsidiary Alza Corporation and Janssen Pharmaceuticals, was the first Fentanyl patch approved by the FDA.  The FDA has received hundreds of reports of fatalities after Fentanyl patch use. The cause of these deaths can be due to seal breaches that allow Fentanyl to leak from the patch (also known as the "fold-over defect"), malfunction of the rate-control membrane, and other defects.  We are currently reviewing cases involving death while using Fentanyl patches.

If you have a loved on who lost their life after using Duragesic, please give our office a call at 1-800-531-9191 or email us at info@wardblacklaw.com.

Back to Defective Products & Medical Devices

Back to What We Do